BNP PARIBAS FINANCIAL MARKETS - RHYTHM PHARMACEUTICALS INC ownership

RHYTHM PHARMACEUTICALS INC's ticker is RYTM and the CUSIP is 76243J105. A total of 85 filers reported holding RHYTHM PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 1.1%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of RHYTHM PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,266,446
+43.9%
55,243
+3.5%
0.00%
+100.0%
Q2 2023$879,824
-66.6%
53,355
-39.1%
0.00%
-75.0%
Q1 2023$2,637,501
+71.3%
87,650
+65.7%
0.00%
+100.0%
Q4 2022$1,539,982
-99.9%
52,884
-34.7%
0.00%
-33.3%
Q3 2022$1,982,858,000
+2221.0%
80,933
+293.1%
0.00%
Q2 2022$85,432,000
-37.0%
20,586
+75.0%
0.00%
Q1 2022$135,521,000
-63.7%
11,764
-68.5%
0.00%
-100.0%
Q4 2021$372,993,000
+161.8%
37,374
+242.6%
0.00%
Q3 2021$142,458,000
+37.4%
10,908
+105.9%
0.00%
Q2 2021$103,715,000
-66.9%
5,297
-64.0%
0.00%
Q1 2021$313,392,000
+119.0%
14,734
+206.1%
0.00%
Q4 2020$143,120,000
-16.5%
4,814
-39.2%
0.00%
Q3 2020$171,496,000
+186.7%
7,914
+195.1%
0.00%
Q2 2020$59,809,000
-69.2%
2,682
-79.0%
0.00%
Q1 2020$194,207,000
+148.1%
12,760
+274.3%
0.00%
Q4 2019$78,271,000
+5.8%
3,409
-0.5%
0.00%
Q3 2019$73,967,000
+99.3%
3,426
+103.1%
0.00%
Q2 2019$37,114,000
-57.2%
1,687
-46.7%
0.00%
Q1 2019$86,780,000
+107035.8%
3,166
+105433.3%
0.00%
Q4 2018$81,000
-99.5%
3
-99.5%
0.00%
Q3 2018$17,356,000
+21.2%
595
+29.9%
0.00%
Q2 2018$14,317,000
-47.7%
458
-66.7%
0.00%
Q1 2018$27,382,000
-42.5%
1,376
-16.1%
0.00%
Q4 2017$47,658,0001,6400.00%
Other shareholders
RHYTHM PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
TRV GP, LLC 2,981,437$86,969,00072.32%
MPM ASSET MANAGEMENT LLC 3,074,893$89,695,00060.73%
Foresite Capital Management IV, LLC 696,903$20,329,0006.66%
NEA Management Company, LLC 4,912,306$143,292,0006.18%
RA Capital Management 1,950,332$56,891,0003.04%
Trustees of Princeton University 47,643$1,390,0001.96%
Greylock XII GP LLC 54,749$1,597,0001.12%
Baker Brothers Advisors 2,708,200$78,998,0000.52%
Perceptive Advisors 664,186$19,374,0000.52%
Sofinnova Investments, Inc. 159,302$4,646,0000.41%
View complete list of RHYTHM PHARMACEUTICALS INC shareholders